August NMBio Program on Targeted Cancer Therapeutics: Presentation

Personalized medicine attempts to tailor medical treatment to the individual’s characteristics and in oncology targets an individual’s tumor with a therapy tailored to the specific characteristics of a tumor. Successful development of targeted therapeutics often relies upon co-development with companion diagnostics. Identifying a specific, responsive patient population within a larger population can enable the approval of a therapeutic, but limit its intended use.

Patrick Burke of Myriad Genetics gave a presentation on “Diagnostic Testing for Targeted Cancer Therapeutics”.  Attached for those of you interested is the PowerPoint presentation..NMBio Myriad Presentation August 2015

Comments are closed.